The FDA approved it in 2019 for hypoactive sexual desire disorder in premenopausal women
Tsai N-P, Wilkerson JR, Guo W, Maksimova MA, DeMartino GN, Cowan CW, et al
The pain reduction going from 28G to 31G is meaningful over the course of a long treatment protocol measured in months
How PTD-DBM Works for Hair Directly activates the Wnt/-catenin pathway, which is suppressed by DHT in androgenetic alopecia Inhibits CXXC5 a negative regulator of the Wnt pathway effectively unblocking the hair growth signal Promotes the conversion of vellus hairs (thin, fine hairs) back into terminal hairs (thick, pigmented hairs) Does not directly interfere with systemic hormones, reducing the risk of sexual side effects associated with finasteride What the Research Says Research from Yonsei University in South Korea demonstrated that PTD-DBM promoted new hair growth in mice within 28 days of topical application
Soft Tissue Repair: Effective in healing sports-related injuries, such as tendon and ligament damage
Pregnant or lactating women and people with any medical condition should consult a doctor before use